Search Within

Virginia Klimek

Formats
  1. Meeting Abstract (78)
  2. Journal Article (64)
  3. Editorial (2)
  4. Research Letter (2)
  5. Book Section (1)
Groups
  1. Adult Leukemia (147)
  2. Center for Hematologic Malignancies (147)
  3. Department of Medicine (147)
  4. Hematologic Malignancies, Division of (147)
  5. GSK Faculty (44)
  6. Epidemiology and Biostatistics (36)

More Groups

People
  1. Stephen Nimer (30)
  2. Sean Devlin (26)
  3. Martin Tallman (22)
  4. Ross Levine (21)
  5. Stephen Chung (18)
  6. Elli Papaemmanuil (14)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (8)
  6. 2019 (14)

More Years

Publications
  1. Blood (54)
  2. Leukemia Research (10)
  3. Journal of Clinical Oncology (9)
  4. Haematologica (8)
  5. Bone Marrow Transplantation (4)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (54)
  2. Nature Publishing Group (17)
  3. American Society of Clinical Oncology (10)
  4. Elsevier Ltd (10)
  5. Ferrata Storti Foundation (8)
  6. American Association for Cancer Research (6)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Pigneux, A.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study
    Journal Article

    Epstein, D. J.; Seo, S. K.; Huang, Y. T.; Park, J. H.; Klimek, V. M.; Berman, E.; Tallman, M. S.; Frattini, M. G.; Papanicolaou, G. A.
    Journal of Infection (2018)

    Fulltext@MSK | Save
  • H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
    Journal Article

    Seiler, M.; Yoshimi, A.; Darman, R.; Chan, B.; Keaney, G.; Thomas, M.; Agrawal, A. A.; Caleb, B.; Csibi, A.; Sean, E.; more...
    Nature Medicine (2018)

    Fulltext@MSK | Save
  • Palliative care from cancer diagnosis for all: Memorial Sloan Kettering's "One-Two-Three'' program
    Meeting Abstract

    Epstein, A.; Klimek, V.; Chow, K.; Desai, A.; Anderson, K.; Rawlins-Duell, R.; Goldberg, J.; Nelson, J.
    Journal of Pain and Symptom Management (2018)

    Fulltext@MSK | Save
  • H3B-8800-G0001-101: A first in human phase I study of a splicing modulator in patients with advanced myeloid malignancies
    Meeting Abstract

    Steensma, D. P.; Maris, M. B.; Yang, J.; Donnellan, W. B.; Brunner, A. M.; McMasters, M.; Greenberg, P.; Komrokji, R. S.; Klimek, V. M.; Goldberg, J. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Palliative care from cancer diagnosis for all: Memorial Sloan Kettering's "One-Two-Three" program
    Meeting Abstract

    Epstein, A. S.; Klimek, V. M.; Chow, K.; Desai, A. V.; Wan, P. J.; Anderson, K.; Ranghan, C.; Okpako, M.; Rawlins-Duell, R.; Kramer, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Myeloid malignancies following luminal gastrointestinal cancer: High incidence of deletion 5q and DNTM3A mutations
    Meeting Abstract

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Klimek, V. M.; Saltz, L. B.; Tallman, M. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report
    Meeting Abstract

    Klimek, V. M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B.
    Leukemia Research (2017)

    Fulltext@MSK | Save